Abstract
Multiple sclerosis (MS) is an autoimmune neurodegenerative disease that is characterized by the demyelinated inflammatory processes that occur within the central nervous system. Hypothalamus–pituitary–adrenal axis (HPA axis) dysfunctions have been associated with the triggering or increase in MS symptoms. We thus aimed at evaluating motor and behavioral functions, planning skills, processing speed, and their relationship with stress through measuring hair cortisol concentration from patients with MS. The sample was composed of 40 volunteers that were clinically diagnosed with MS, along with 33 healthy adults. Evaluations included: Clinical Evaluation Form, Mini-Mental State Exam, Hamilton Depression Rating Scale, Multiple Sclerosis Functional Composite Measure, Expanded Disability Status Scale, Berg Balance Scale, Perceived Stress Scale, Zoo Map task, and a hair sample to analyze cortisol levels in the last 30 days. MS patients showed highly elevated hair cortisol levels in comparison to the control group (p = 0.048). All groups presented some degree of depressive and anxiety symptoms, aside from considerable perceived stress levels. The MS group presented deficits in gait, balance, manual skills and processing speed, and this was particularly so in individuals with moderate impairments when compared to control group (p < 0.001). Individuals with MS spent less time planning on ZooMap1 (p = 0.024) and made more mistakes (p < 0.001). No correlation was found between hair cortisol and the symptoms we assessed. However, depressive symptoms and anxiety were related to perceived stress, and higher hair cortisol suggests a change in levels in the HPA axis in MS. Nevertheless, future studies will be necessary to further understand how basal hair cortisol is related to MS symptoms.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Akcali A, Zengin F, Aksoy SN, Zengin O (2017) Fatigue in multiple sclerosis: is it related to cytokines and hypothalamic-pituitary adrenal axis? Mult Scler Relat Disord 15:37–41. https://doi.org/10.1016/j.msard.2017.03.004
Altowaijri G, Fryman A, Yadav V (2017) Dietary interventions and multiple sclerosis. Curr Neurol Neurosci Rep 17(3):28. https://doi.org/10.1007/s11910-017-0732-3
Arnett PA, Higginson CI, Randolph JJ (2001) Depression in multiple sclerosis: relationship to planning ability. J Int Neuropsychol Soc 7(6):665–674. https://doi.org/10.1017/S1355617701766027
Artemiadis AK, Anagnostouli MC, Alexopoulos EC (2011) Stress as a risk factor for multiple sclerosis onset or relapse: a systematic review. Neuroepidemiology 36(2):109–120. https://doi.org/10.1159/000323953
Baranowska-Bik A, Kochanowski J, Uchman D, Litwiniuk A, Kalisz M, Martynska L, Wolinska-Witort E, Baranowska B, Bik W (2015) Association of copeptin and cortisol in newly diagnosed multiple sclerosis patients. J Neuroimmunol 282:21–24. https://doi.org/10.1016/j.jneuroim.2015.03.011
Bellmann-Strobl J, Wuerfel J, Aktas O, Dörr J, Wernecke KD, Zipp F, Paul F (2009) Poor PASAT performance correlates with MRI contrast enhancement in multiple sclerosis. Neurology 73(20):1624–1627. https://doi.org/10.1212/wnl.0b013e3181c1de4f
Benedetti MG, Piperno R, Simoncini L, Bonato P, Tonini A, Giannini S (1999) Gait abnormalities in minimally impaired multiple sclerosis patients. Mult Scler 5(5):363–368. https://doi.org/10.1177/135245859900500510
Berg K, Wood-Dauphinée S, Williams JI (1989) Measuring balance in the elderly: preliminary development of an instrument. Physiother Can 41:304–311. https://doi.org/10.3138/ptc.41.6.304
Boeckel MG, Wagner A, Grassi-Oliveira R (2016) The effects of intimate partner violence exposure on the maternal bond and PTSD symptoms of children. J Interpers Viol 32(7):1127–1142. https://doi.org/10.1177/0886260515587667
Brassington JC, Marsh NV (1998) Neuropsychological aspects of multiple sclerosis. Neuropsychol Rev 8(2):43–77. https://doi.org/10.1023/A:1025621700003
Buchweitz A, de Azeredo LA, Vieira BS, Cará VM, Esper NB, Soder RB, Costa JC, Portuguez MW, Franco AR, Grassi-Oliveira R (2019) Violence and Latin-American children and adolescents: a study of social brain function and cortisol levels. Dev Sci. https://doi.org/10.1111/desc.12799
Carling A, Forsberg A, Nilsagård Y (2016) Berg balance scale and timed up and go discriminates between fallers and non-fallers, in people with MS. In: Sixth international symposium on gait and balance in multiple sclerosis. http://oru.diva-portal.org/smash/record.jsf?pid=diva2%3A1076262&dswid=-6837. Accessed 26 Feb 2019
Cattaneo D, Regola A, Meotti M (2006) Validity of six balance disorders scales in persons with multiple sclerosis. Disabil Rehabil 28(12):789–795. https://doi.org/10.1080/09638280500404289
Ciriaco M, Ventrice P, Russo G, Scicchitano M, Mazzitello G, Scicchitano F, Russo E (2013) Corticosteroid-related central nervous system side effects. J Pharmacol Pharmacother 4(Suppl 1):S94–S98. https://doi.org/10.4103/0976-500X.120975
Cohen S, Kamarck T, Mermelstein R (1983) A global measure of perceived stress. J Health Soc Behav 24(4):385–396
Coric D, Balk LJ, Verrijp M, Eijlers A, Schoonheim MM, Killestein J, Uitdehaag BM, Petzold A (2018) Cognitive impairment in patients with multiple sclerosis is associated with atrophy of the inner retinal layers. Mult Scler 24(2):158–166. https://doi.org/10.1177/1352458517694090
Demaree HA, DeLuca J, Gaudino EA, Diamond BJ (1999) Speed of information processing as a key deficit in multiple sclerosis: implications for rehabilitation. J Neurol Neurosurg Psychiatry 67(5):661–663. https://doi.org/10.1136/jnnp.67.5.661
Ebers GC (2008) Environmental factors and multiple sclerosis. Lancet Neurol 7(3):268–277. https://doi.org/10.1016/S1474-4422(08)70042-5
Erkut ZA, Hofman MA, Ravid R, Swaab DF (1995) Increased activity of hypothalamic corticotropin-releasing hormone neurons in multiple sclerosis. J Neuroimmunol 62(1):27–33. https://doi.org/10.1016/0165-5728(95)00098-M
Erkut ZA, Endert E, Huitinga I, Swaab DF (2002) Cortisol is increased in postmortem cerebrospinal fluid of multiple sclerosis patients: relationship with cytokines and sepsis. Mult Scler 8(3):229–236. https://doi.org/10.1191/1352458502ms797oa
Fassbender K, Schmidt R, Mössner R, Kischka U, Kühnen J, Schwartz A, Hennerici M (1998) Mood disorders and dysfunction of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: association with cerebral inflammation. Arch Neurol 55(1):66–72. https://doi.org/10.1001/archneur.55.1.66
Fischer JS, Rudick RA, Cutter GR, Reingold SC (1999) The multiple sclerosis functional composite measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force. Mult Scler 5(4):244–250. https://doi.org/10.1177/135245859900500409
Fjeldstad C, Pardo G, Frederiksen C, Bemben D, Bemben M (2009) Assessment of postural balance in multiple sclerosis. Int J MS Care 11:1–5. https://doi.org/10.7224/1537-2073-11.1.1
Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189–198. https://doi.org/10.1016/0022-3956(75)90026-6
Forn C, Belenguer A, Parcet-Ibars MA, Avila C (2008) Information-processing speed is the primary deficit underlying the poor performance of multiple sclerosis patients in the paced auditory serial addition test (PASAT). J Clin Exp Neuropsychol 30(7):789–796. https://doi.org/10.1080/13803390701779560
Frzovic D, Morris ME, Vowels L (2000) Clinical tests of standing balance: performance of persons with multiple sclerosis. Arch Phys Med Rehabil 81(2):215–221
Gold SM, Raji A, Huitinga I, Wiedemann K, Schulz KH, Heesen C (2005) Hypothalamo-pituitary-adrenal axis activity predicts disease progression in multiple sclerosis. J Neuroimmunol 165(1–2):186–191. https://doi.org/10.1016/j.jneuroim.2005.04.014
Gold SM, Kern KC, O’Connor MF, Montag MJ, Kim A, Yoo YS, Giesser BS, Sicotte NL (2010) Smaller cornu ammonis 2-3/dentate gyrus volumes and elevated cortisol in multiple sclerosis patients with depressive symptoms. Biol Psychiatry 68(6):553–559. https://doi.org/10.1016/j.biopsych.2010.04.025
Gold SM, Krüger S, Ziegler KJ, Krieger T, Schulz KH, Otte C, Heesen C (2011) Endocrine and immune substrates of depressive symptoms and fatigue in multiple sclerosis patients with comorbid major depression. J Neurol Neurosurg Psychiatry 82(7):814–818. https://doi.org/10.1136/jnnp.2010.230029
Guimarães J, Sá MJ (2012) Cognitive dysfunction in multiple sclerosis. Front Neurol 3:74. https://doi.org/10.3389/fneur.2012.00074
Gunn H, Markevics S, Haas B, Marsden J, Freeman J (2015) Systematic review: the effectiveness of interventions to reduce falls and improve balance in adults with multiple sclerosis. Arch Phys Med Rehabil 96(10):1898–1912. https://doi.org/10.1016/j.apmr.2015.05.018
Hamilton M (1959) The assessment of anxiety states by rating. Br J Med Psychol 32:50–55. https://doi.org/10.1111/j.2044-8341.1959.tb00467.x
Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62. https://doi.org/10.1136/jnnp.23.1.56
Heesen C, Haase R, Melzig S, Poettgen J, Berghoff M, Paul F, Zettl U, Marziniak M, Angstwurm K, Kern R, Ziemssen T, Stellmann JP (2017) Perceptions on the value of bodily functions in multiple sclerosis. Acta Neurol Scand 137(3):356–362. https://doi.org/10.1111/ane.12881
Hoang PD, Cameron MH, Gandevia SC, Lord SR (2014) Neuropsychological, balance, and mobility risk factors for falls in people with multiple sclerosis: a prospective cohort study. Arch Phys Med Rehabil 95(3):480–486. https://doi.org/10.1016/j.apmr.2013.09.017
Huitinga I, Erkut ZA, van Beurden D, Swaab DF (2004) Impaired hypothalamus-pituitary-adrenal axis activity and more severe multiple sclerosis with hypothalamic lesions. Ann Neurol 55(1):37–45. https://doi.org/10.1002/ana.10766
Joffe RT, Lippert GP, Gray TA, Sawa G, Horvath Z (1987) Mood disorder and multiple sclerosis. Arch Neurol 44(4):376–378. https://doi.org/10.1001/archneur.1987.00520160018007
Jones KH, Ford DV, Jones PA, John A, Middleton RM, Lockhart-Jones H, Osborne LA, Noble JG (2012) A large-scale study of anxiety and depression in people with multiple sclerosis: a survey via the web portal of the UK MS register. PLoS ONE 7(7):e41910. https://doi.org/10.1371/journal.pone.0041910
Kalmar JH, Gaudino EA, Moore NB, Halper J, Deluca J (2008) The relationship between cognitive deficits and everyday functional activities in multiple sclerosis. Neuropsychology 22(4):442–449. https://doi.org/10.1037/0894-4105.22.4.442
Kasser SL, Jacobs JV, Foley JT, Cardinal BJ, Maddalozzo GF (2011) A prospective evaluation of balance, gait, and strength to predict falling in women with multiple sclerosis. Arch Phys Med Rehabil 92(11):1840–1846. https://doi.org/10.1016/j.apmr.2011.06.004
Kern S, Schultheiss T, Schneider H, Schrempf W, Reichmann H, Ziemssen T (2011) Circadian cortisol, depressive symptoms and neurological impairment in early multiple sclerosis. Psychoneuroendocrinology 36(10):1505–1512. https://doi.org/10.1016/j.psyneuen.2011.04.004
Kern S, Krause I, Horntrich A, Thomas K, Aderhold J, Ziemssen T (2013) Cortisol awakening response is linked to disease course and progression in multiple sclerosis. PLoS ONE 8(4):e60647. https://doi.org/10.1371/journal.pone.0060647
Kierkegaard M, Einarsson U, Gottberg K, von Koch L, Holmqvist LW (2012) The relationship between walking, manual dexterity, cognition and activity/participation in persons with multiple sclerosis. Mult Scler 18(5):639–646. https://doi.org/10.1177/1352458511426736
Kirschbaum C, Tietze A, Skoluda N, Dettenborn L (2009) Hair as a retrospective calendar of cortisol production-increased cortisol incorporation into hair in the third trimester of pregnancy. Psychoneuroendocrinology 34:32–37. https://doi.org/10.1016/j.psyneuen.2008.08.024
Kraft GH, Amtmann D, Bennett SE, Finlayson M, Sutliff MH, Tullman M, Sidovar M, Rabinowicz AL (2014) Assessment of upper extremity function in multiple sclerosis: review and opinion. Postgrad Med 126(5):102–108. https://doi.org/10.3810/pgm.2014.09.2803
Krieger SC, Cook K, De Nino S, Fletcher M (2016) The topographical model of multiple sclerosis: a dynamic visualization of disease course. Neurol Neuroimmunol Neuroinflamm 3(5):e279. https://doi.org/10.1212/NXI.0000000000000279
Kümpfel T, Schwan M, Weber F, Holsboer F, Trenkwalder C, Then Bergh F (2014) Hypothalamo-pituitary-adrenal axis activity evolves differentially in untreated versus treated multiple sclerosis. Psychoneuroendocrinology 45:87–95. https://doi.org/10.1016/j.psyneuen.2014.03.012
Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33(11):1444–1452
Lassmann H, Brück W, Lucchinetti CF (2007) The immunopathology of multiple sclerosis: an overview. Brain Pathol 17(2):210–218. https://doi.org/10.1111/j.1750-3639.2007.00064.x
Lipp I, Tomassini V (2015) Neuroplasticity and motor rehabilitation in multiple sclerosis. Front Neurol 6:59. https://doi.org/10.3389/fneur.2015.00059
Loma I, Heyman R (2011) Multiple sclerosis: pathogenesis and treatment. Curr Neuropharmacol 9(3):409–416. https://doi.org/10.2174/157015911796557911
Lotrich FE, El-Gabalawy H, Guenther LC, Ware CF (2011) The role of inflammation in the pathophysiology of depression: different treatments and their effects. J Rheumatol Suppl 88:48–54. https://doi.org/10.3899/jrheum.110903
Lowe MJ, Horenstein C, Hirsch JG, Marrie RA, Stone L, Bhattacharyya PK, Gass A, Phillips MD (2006) Functional pathway-defined MRI diffusion measures reveal increased transverse diffusivity of water in multiple sclerosis. Neuroimage 32:1127–1133. https://doi.org/10.1016/j.neuroimage.2006.04.208
Luft CDB, Sanches SO, Mazo GZ, Andrade A (2007) Brazilian version of the perceived stress scale: translation and validation for the elderly. Rev Saúde Pública 41(4):606–615. https://doi.org/10.1590/S0034-89102007000400015
Martin CL, Phillips BA, Kilpatrick TJ, Butzkueven H, Tubridy N, McDonald E, Galea MP (2006) Gait and balance impairment in early multiple sclerosis in the absence of clinical disability. Mult Scler 12:620–628. https://doi.org/10.1177/1352458506070658
Melief J, De Wit SJ, Van Eden CG, Teunissen C, Hamann J, Uitdehaag BM, Swaab D, Huitinga I (2013) HPA axis activity in multiple sclerosis correlates with disease severity, lesion type and gene expression in normal-appearing white matter. Acta Neuropathol 126(2):237–249. https://doi.org/10.1007/s00401-013-1140-7
Minden SL, Feinstein A, Kalb RC, Miller D, Mohr DC, Patten SB, Bever C, Schiffer RB, Gronseth GS, Narayanaswami P (2014) Evidence-based guideline: assessment and management of psychiatric disorders in individuals with multiple sclerosis. Report of the guideline development subcommittee of the American Academy of Neurology. Neurology 82:174–181. https://doi.org/10.1212/WNL.0000000000000013
Ortiz P, Bareno J, Cabrera L, Rueda K, Rovira A (2017) Magnetic resonance imaging with gadolinium in the acute phase of relapses in multiple sclerosis. Rev Neurol 64:241–246. https://doi.org/10.33588/rn.6406.2016310
Ozturk A, Smith SA, Gordon-Lipkin EM, Harrison DM, Shiee N, Pham DL, Caffo BS, Calabresi PA, Reich DS (2010) MRI of the corpus callosum in multiple sclerosis: association with disability. Mult Scler 16:166–177. https://doi.org/10.1177/1352458509353649
Paul F (2016) Pathology and MRI: exploring cognitive impairment in MS. Acta Neurol Scand 134(200):24–33. https://doi.org/10.1111/ane.12649
Pearson M, Dieberg G, Smart N (2015) Exercise as a therapy for improvement of walking ability in adults with multiple sclerosis: a meta-analysis. Arch Phys Med Rehabil 96:1339–1348.e7. https://doi.org/10.1016/j.apmr.2015.02.011
Penner IK, Paul F (2017) Fatigue as a symptom or comorbidity of neurological diseases. Nat Rev Neurol 13(11):662–675. https://doi.org/10.1038/nrneurol.2017.117
Pereira GM, Soares NM, Souza AR, Becker J, Finkelsztejn A, Almeida RMM (2018) Basal cortisol levels and the relationship with clinical symptoms in multiple sclerosis: a systematic review. Arq Neuropsiquiatr 76(9):622–634. https://doi.org/10.1590/0004-282x20180091
Phé V, Chartier-Kastler E, Panicker JN (2016) Management of neurogenic bladder in patients with multiple sclerosis. Nat Rev Urol 13:275–288. https://doi.org/10.1038/nrurol.2016.53
Pilutti LA, Greenlee TA, Motl RW, Nickrent MS, Petruzzello SJ (2013) Effects of exercise training on fatigue in multiple sclerosis: a meta-analysis. Psychosom Med 75:575–580. https://doi.org/10.1097/PSY.0b013e31829b4525
Powell DJ, Moss-Morris R, Liossi C, Schlotz W (2015) Circadian cortisol and fatigue severity in relapsing-remitting multiple sclerosis. Psychoneuroendocrinology 56:120–131. https://doi.org/10.1016/j.psyneuen.2015.03.010
Preiningerova JL, Novotna K, Rusz J, Sucha L, Ruzicka E, Havrdova E (2015) Spatial and temporal characteristics of gait as outcome measures in multiple sclerosis (EDSS 0 to 6.5). J Neuroeng rehabil 12:14. https://doi.org/10.1186/s12984-015-0001-0
Reder AT, Mackowiec RL, Lowy MT (1994) Adrenal size is increased in multiple sclerosis. Arch Neurol 51:151–154. https://doi.org/10.1001/archneur.1994.00540140057015
Reis RS, Petroski EL (2004) Reliability and validity of the Brazilian version of the perceived stress scale. Prev Med (in press)
Sakai RE, Feller DJ, Galetta KM, Galetta SL, Balcer LJ (2011) Vision in multiple sclerosis: the story, structure-function correlations, and models for neuroprotection. J Neuroophthalmol 31(4):362–373. https://doi.org/10.1097/WNO.0b013e318238937f
Sauvé B, Koren G, Walsh G, Tokmakejian S, Van Uum SHM (2007) Measurement of cortisol in human hair as a biomarker of systemic exposure. Clin Invest Med 30(5):183–191. https://doi.org/10.25011/cim.v30i5.2894
Scheffer M, Becker J, de Azeredo LA, Grassi-Oliveira R, de Almeida RMM (2019) Subjective and physiological stress measurement in a multiple sclerosis sample and the relation with executive functions performance. J Neural Transm (Vienna). https://doi.org/10.1007/s00702-019-01981-6
Soyuer F, Mirza M, Erkorkmaz U (2006) Balance performance in three forms of multiple sclerosis. Neurol Res 28:555–562. https://doi.org/10.1179/016164105X49373
Sullivan MJ, Weinshenker B, Mikail S, Bishop SR (1995) Screening for major depression in the early stages of multiple sclerosis. Can J Neurol Sci 22:228–231. https://doi.org/10.1017/S0317167100039895
Then Bergh F, Kümpfel T, Trenkwalder C, Rupprecht R, Holsboer F (1999) Dysregulation of the hypothalamo-pituitary-adrenal axis is related to the clinical course of MS. Neurology 53(4):772–777. https://doi.org/10.1212/WNL.53.4.772
Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17(2):162–173. https://doi.org/10.1016/s1474-4422(17)30470-2
Van Der Meij L, Gubbels N, Schaveling J, Almela M, Van Vugt M (2018) Hair cortisol and work stress: importance of workload and stress model (JDCS or ERI). Psychoneuroendocrinology 26(89):78–85. https://doi.org/10.1016/j.psyneuen.2017.12.020
Wennig R (2000) Potential problems with the interpretation of hair analysis results. Forensic Sci Int 107(1–3):5–12. https://doi.org/10.1016/S0379-0738(99)00146-2
Weygandt M, Meyer-Arndt L, Behrens JR, Wakonig K, Bellmann-Strobl J, Ritter K, Scheel M, Brandt AU, Labadie C, Hetzer S, Gold SM, Paul F, Haynes JD (2016) Stress-induced brain activity, brain atrophy, and clinical disability in multiple sclerosis. Proc Natl Acad Sci USA 113(47):13444–13449. https://doi.org/10.1073/pnas.1605829113
Wilson BA, Alderman N, Burgess PW, Emslie H, Evans JJ (1996) The behavioural assessment of the dysexecutive syndrome. Thames Valley Company, Bury St Edmunds
Yozbatiran N, Baskurt F, Baskurt Z, Ozakbas S, Idiman E (2006) Motor assessment of upper extremity function and its relation with fatigue, cognitive function and quality of life in multiple sclerosis patients. J Neurol Sci 246:117–122. https://doi.org/10.1016/j.jns.2006.02.018
Ysrraelit MC, Gaitán MI, Lopez AS, Correale J (2008) Impaired hypothalamic-pituitary-adrenal axis activity in patients with multiple sclerosis. Neurology 71(24):1948–1954. https://doi.org/10.1212/01.wnl.0000336918.32695.6b
Acknowledgements
This work was conducted during a scholarship of Graduate Education, which was supported by the CNPq at the UFRGS.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in the studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee (Committee of Ethics in Research in Human Beings of UFRGS, no. 2.014.963).
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Pereira, G.M., Becker, J., Soares, N.M. et al. Hair cortisol concentration, cognitive, behavioral, and motor impairment in multiple sclerosis. J Neural Transm 126, 1145–1154 (2019). https://doi.org/10.1007/s00702-019-02040-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-019-02040-w